Companion Medical Raises $3M For Bluetooth-Enabled Insulin Delivery System

San Diego-based Companion Medical, a developer of a Bluetooth- and smartphone app-enabled insulin delivery system for diabetics, has raised $3M in a Series B funding, the company said this week. The funding came from Eli Lilly & Company. Companion Medical, which is led by Sean Saint, develops an "insulin pen" which is Bluetooth enabled, and connects to a smartphone app, to deliver insulin to patients when needed.